BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16339499)

  • 1. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
    Ferreira IA; Mocking AI; Feijge MA; Gorter G; van Haeften TW; Heemskerk JW; Akkerman JW
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):417-22. PubMed ID: 16339499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S; Tamura N; Ishida H; Ruggeri ZM
    J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
    Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
    Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
    Hardy AR; Hill DJ; Poole AW
    Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
    Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
    Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
    Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
    Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
    Leon C; Ravanat C; Freund M; Cazenave JP; Gachet C
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1941-7. PubMed ID: 12933533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual P2Y 12 receptor signaling in thrombin-stimulated platelets--involvement of phosphoinositide 3-kinase beta but not gamma isoform in Ca2+ mobilization and procoagulant activity.
    van der Meijden PE; Schoenwaelder SM; Feijge MA; Cosemans JM; Munnix IC; Wetzker R; Heller R; Jackson SP; Heemskerk JW
    FEBS J; 2008 Jan; 275(2):371-85. PubMed ID: 18081863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
    Shen J; DiCorleto PE
    Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function.
    Judge HM; Buckland RJ; Sugidachi A; Jakubowski JA; Storey RF
    Thromb Haemost; 2010 Jun; 103(6):1210-7. PubMed ID: 20431852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets Express Activated P2Y
    Hu L; Chang L; Zhang Y; Zhai L; Zhang S; Qi Z; Yan H; Yan Y; Luo X; Zhang S; Wang Y; Kunapuli SP; Ye H; Ding Z
    Circulation; 2017 Aug; 136(9):817-833. PubMed ID: 28637879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability.
    van Gestel MA; Heemskerk JW; Slaaf DW; Heijnen VV; Reneman RS; oude Egbrink MG
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):518-23. PubMed ID: 12615691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study.
    Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D
    Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3-kinase is essential for ADP-stimulated integrin alpha(IIb)beta3-mediated platelet calcium oscillation, implications for P2Y receptor pathways in integrin alpha(IIb)beta3-initiated signaling cross-talks.
    Sun DS; Lo SJ; Tsai WJ; Lin CH; Yu MS; Chen YF; Chang HH
    J Biomed Sci; 2005 Dec; 12(6):937-48. PubMed ID: 16228296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
    Manolopoulos P; Glenn JR; Fox SC; May JA; Dovlatova NL; Tang SW; Thomas NR; Ralevic V; Heptinstall S
    Platelets; 2008 Mar; 19(2):134-45. PubMed ID: 18297551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.